Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-15
2007-05-15
Hayes, Robert C. (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S397000, C536S023510, C435S320100, C435S325000
Reexamination Certificate
active
08479892
ABSTRACT:
Erythropoietin analogs having at least one additional site for glycosylation, or a rearrangement of at least one site for glycosylation are disclosed. The invention also relates to DNA sequences encoding said erythropoietin analogs, and recombinant plasmids and host cells for analog expression.
REFERENCES:
patent: 4397840 (1983-08-01), Takezawa et al.
patent: 4667016 (1987-05-01), Lai
patent: 4703008 (1987-10-01), Lin
patent: 5041376 (1991-08-01), Gething et al.
patent: 5217881 (1993-06-01), Park
patent: 5218092 (1993-06-01), Sasaki et al.
patent: 90/59145 (1991-01-01), None
patent: A-59145/90 (1991-01-01), None
patent: 0 148 605 (1985-07-01), None
patent: 148605 (1985-07-01), None
patent: 0 267 678 (1988-05-01), None
patent: 267678 (1988-05-01), None
patent: 0 357 804 (1990-03-01), None
patent: 357804 (1990-03-01), None
patent: 0 370 205 (1990-05-01), None
patent: 370205 (1990-05-01), None
patent: 0 428 267 (1991-05-01), None
patent: 428267 (1991-05-01), None
patent: 0 640 619 (1997-07-01), None
patent: WO 89/03840 (1989-05-01), None
patent: 90/14363 (1990-11-01), None
patent: WO 90/14363 (1990-11-01), None
patent: WO 00/24893 (2000-05-01), None
Rudinger In “Peptide Hormones” (Jun. 1976) ed. J.A. Parsons, University Park Press, Baltimore pp. 1-7.
Ashwell et al. Methods Enzymol. 50, 287-288 (1978).
Boissel et al. in The Biology of Hematopoiesis pp. 227-232 (1990).
Boissel et al. J. Biol. Chem. 268, 15983-15993 (1993).
Bradford Anal. Biochem. 72, 248-254 (1976).
Briggs et al. Am. J. Physiol. 227, 1385-1388 (1974).
Chern et al. Eur. J. Biochem. 202, 225-229 (1991).
Delorme et al. Biochemistry 31, 9871-9876 (1992).
Dube et al. J. Biol. Chem. 263, 17516-17521 (1988).
Elliott et al. Abstract of Presentation at Keystone Symposium, Mar. 21-27, 1992.
Elliott et al. J. Cell. Biochem. Supp. 15G, Abstract No. R215 (1991).
Elliott et al. J. Cell Biochem. Supp. 17B, Abstract No. E318 (1993).
Kessler et al. J. Biol. Chem. 254, 7901-7908 (1979).
Lin et al. in Molecular and Cellular Aspects of Erythropoietin & Erythropoiesis, I.N. Rich., ed., Springer-Verlag, Berlin 12-36 (1987).
Pierce et al. Ann. Rev. Biochem. 50, 465-495 (1981).
Yamaguchi et al. J. Biol. Chem. 266, 20434-20439 (1991).
Gavel et al. (1990),Protein Engineering, 3(5):433-442.
Shakin-Eshleman (1996),Trends in Glycoscience and Glycotechnology, 8(40):115-130.
Chou and Fasman (1978),Adv. Enzymol. ,47:45-148.
Garnier et al. (1978),J. Mol. Biol., 120:97-120.
Lim (1974),J. Mol. Biol., 88:873-894.
Burbaum et al. (1990)Proteins7:99-111.
Kyngas et al. (1998),Protein Engineering, 11(5):345-348.
Gallagher et al. (1988),J. Cell Biology, 107:2059-2073.
Dordal et al. (1985),Endocrinology, 116(6):2293-2299.
Dube et al. (1988),J. Biol. Chem., 263(33):17516-17521.
Watowich et al. (1994),Molecular and Cellular Biology, 14(6):3535-3549.
Ashwell et al., “A Protein from Mammalian Liver That Specifically Binds Galactose-Terminated Glycoproteins”,Methods Enzymol. 50:287-288 1978).
Boissel et al., “Erythropoietin Structure-Function Relationships”,The Biology of Hematopoiesispp. 227-232 (1990).
Boissel et al., “Erythropoietin Structure-Function Relationships”,J. Biol. Chem. 268:15983-15993 (1993).
Bradford, “A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding”,Anal. Biochem. 72:248-254 (1976.
Briggs et al., “Hepatic clearance of intact and desialylated erythropoietin”,Am. J. Physiol. 227:1385-1388 (1974).
Broudy et al., “Recombinant Human Erythropoietin: Purification and Analysis of Carbohydrate Linkage”,Arch. Biochem. Biophys. 265:329-336 (1988).
Burnette, “Western Blotting: Electrophoretic Transfer of Proteins from Sodium Dodecyl Sulfate-Polyacrylamide Gels to Unmodified Nitrocellulose and Radiographic Detection with Antibody and Radioiodinated Protein A”,Anal. Biochem. 112:195-203 (1981).
Chern et al., “Structural role of amino acids 99-110 in recombinant human erythropoietin”,Eur. J. Biochem. 202:225-229 (1991).
Cheetham et al. “NMR Structure of Human Erythropoietin and a Comparison with its Receptor Bound Conformation,”Nature5(10):861-866.
Cotes et al., “Bio-assay of Erythropoietin in Mice Made Polycythaemic by Exposure to Air at a Reduced Pressure”,Nature191:1065-1067 (1961).
Davis et al., “Characterization of Recombinant Human Erythropoietin Produced in Chinese Hamster Ovary Cells”,Biochemistry26:2633-2638 (1987).
Delorme et al., “Role of Glycosylation on the Secretion and Biological Activity of Erythropoietin”,Biochemistry31:9871-9876 (1992).
Dorado et al., “Electrophoretic Behavior of Erythropoietin in Polyacrylamide Gel”,Biochem. Medicine6:238-245 (1972).
Dordal et al., “The Role of Carbohydrate in Erythropoietin Action”,Endocrinology116:2293-2299 (1985).
Dube et al., “Glycosylation at Specific Sites of Erythropoietin is Essential for Biosynthesis, Secretion, and Biological Function”,J. Biol. Chem. 263:17516-17521 (1988).
Egrie et al., “Characterization and Biological Effects of Recombinant Human Erythropoietin”,Immunobiology172:213-224 (1986).
Egrie et al., “Pharmacokinetics of Recombinant Human Erythropoietin (rHeEpo) Administered to Hemodialysis (HD) Patients,”Kidney Intl. 33:262 (1988).
Egrie et al. (1997),Blood90(1):56A, Abstract 243.I.
Elliott et al., “Structural Requirements for O-Linked Glycosylation of Human Erythropoietin”, Abstract of Presentation at Keystone Symposium, Mar. 21-27, 1992
Elliott et al., “Structural Requirements for O-Linked Glycosylation of Human Erythropoietin”, Abstracts of the Protein Society, 5th Symp, Abstract No. M43 (1991).
Elliott et al., “Characterization of Anti Erythropoietin Monoclonal Antibodies”,Blood74(Supp. 1):A 1228 (1989).
Elliott et al., “Secretion of glycosylated human erythropoietin from yeast directed by the α—factor leader region”,Gene79:167-180 (1989).
Elliott et al. , “An Immunological Approach to Determination of Protein Structure: Human Erythropoietin”,J. Cell. Biochem. Supp. 15G, Abstract No. R215 (1991).
Elliott et al., “Effect of Disulfide Bonds on the Structure and Activity of Erythropoietin”,J. Cell. Biochem. Supp. 17B, Abstract No. E318 (1993).
Emini et al. “Induction of Hepatitis A Virus-Neutralizing Antibody by a Virus-Specific Synthetic Peptide,”J. Virology55(3):836-839.
Fu, et al. (1993), “The sheep erythropoietin gene: molecular cloning and effect of hemorrhage on plasma erythropoietin and renal/liver messenger RNA in adult sheep,”Molecular and Cellular Endocrinology93:107-116.
Fuhr et al., “Evaluation of Commercial Erythropoietin Activity after Preparative Isoelectric Focusing”,Biochem. Biophys. Res. Comm. 98:930-935 (1981).
Fukuda et al., “Survival of Recombinant Erythropoietin in the Circulation: The Role of Carbohydrates”,Blood73:84-89 (1989).
Fukuda et al. (1990), “Structure and Role of Carbohydrate in Human Erythropoietin,”Adv. Exp. Med. Biol. 271:53-68.
Goldwasser et al., “On the Mechanism of Erythropoietin-induced Differentiation”,J. Biol. Chem. 249:4202-4206 (1974).
Holmes et al., “A Rapid Boiling Method for the Preparation of Bacterial Plasmids”,Anal. Biochem. 117:193-197 (1981).
Imai et al. (1990), “Physicochemical and biological characterization of asialoerythropoietin,”Eur. J. Biochem. 194:457-462.
Iscove et al., “Erythroid Colony Formation in Cultures of Mouse and Human Bone Marrow Analysis of the Requirement for Erythropoietin by Gel Filtration and Affinity Chromatography on Agarose-Concanavalin A”,J. Cell Physiol. 83:309-320 (1974).
Jacobs et al. (1985), “Isolation and characterization of genomic and cDNA clones of human erythropoietin,”Nature313:806-810.
Kessler et al., “Structures ofN-Glyco
Byrne Thomas E.
Elliott Steven G.
Amgen Inc.
Hayes Robert C.
Marshall & Gerstein & Borun LLP
LandOfFree
Glycosylation analogs of erythropoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycosylation analogs of erythropoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosylation analogs of erythropoietin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3725583